Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China flag China · Delayed Price · Currency is CNY
41.06
-0.49 (-1.18%)
Apr 9, 2026, 3:00 PM CST

SHA:600329 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,0162,9442,1252,8832,283
Short-Term Investments
-1,00061.740.61109.64
Cash & Short-Term Investments
1,0163,9452,1872,9232,393
Cash Growth
-74.23%80.37%-25.19%22.16%20.40%
Accounts Receivable
1,5711,3162,6532,7251,971
Other Receivables
9.438.5634.160.7740.73
Receivables
1,5811,3252,6872,7852,011
Inventory
1,1331,2861,5671,4291,525
Other Current Assets
3,42452.96111.07107.5495.77
Total Current Assets
7,1556,6086,5527,2456,425
Property, Plant & Equipment
1,1421,3931,4421,4651,486
Long-Term Investments
1,1661,294882.67801.46740.74
Goodwill
-12.365.9184.69-
Other Intangible Assets
292.75295.29317.75281.13198.19
Long-Term Deferred Tax Assets
341.01314.4265.99208.35154.6
Long-Term Deferred Charges
52.8366.0718.317.544.72
Other Long-Term Assets
1,541785.43686.2953.7757.51
Total Assets
11,69010,76910,23010,1579,067
Accounts Payable
218.05284.511,1261,4061,242
Accrued Expenses
225.051,7871,4931,170679.77
Short-Term Debt
57.921.6581.8101.64-
Current Portion of Long-Term Debt
3.12---30
Current Portion of Leases
-1.333.564.11.6
Current Income Taxes Payable
115.93297.5776.6893.289.53
Current Unearned Revenue
148.53123.14145.66219.07215.61
Other Current Liabilities
3,738302.52305.66339.37254.89
Total Current Liabilities
4,5062,8183,2333,3332,434
Long-Term Debt
-10251.03161.310
Long-Term Leases
4.665.62.740.871.57
Long-Term Unearned Revenue
45.4955.1457.1459.8859.15
Long-Term Deferred Tax Liabilities
0.286.047.338.824.21
Other Long-Term Liabilities
32.9324.0733.6940.7344.42
Total Liabilities
4,5902,9193,5853,6052,553
Common Stock
770.09770.09770.16773.44773.44
Additional Paid-In Capital
974.98974.79975.211,0481,374
Retained Earnings
5,3306,0724,8284,7004,218
Treasury Stock
---7.04-29.75-32.03
Comprehensive Income & Other
24.0726.9334.3429.5330.62
Total Common Equity
7,0997,8446,6016,5216,364
Minority Interest
0.456.3444.5530.49149.35
Shareholders' Equity
7,1007,8506,6456,5526,514
Total Liabilities & Equity
11,69010,76910,23010,1579,067
Total Debt
65.6838.59339.14267.9143.17
Net Cash (Debt)
950.743,9061,8482,6552,350
Net Cash Growth
-75.66%111.39%-30.41%13.01%20.83%
Net Cash Per Share
1.245.062.403.423.05
Filing Date Shares Outstanding
771.38770.09770.16773.44773.44
Total Common Shares Outstanding
771.38770.09770.16773.44773.44
Working Capital
2,6483,7903,3193,9123,991
Book Value Per Share
9.2010.198.578.438.23
Tangible Book Value
6,8077,5366,2176,1566,166
Tangible Book Value Per Share
8.829.798.077.967.97
Buildings
-1,3251,3381,3371,323
Machinery
-1,0661,1071,0871,028
Construction In Progress
-436.35386.46333.85331.62
Source: S&P Global Market Intelligence. Standard template. Financial Sources.